Diagnostic and Management Strategies in Patients with Late Recurrent Angina after Coronary Artery Bypass Grafting
- PMID: 35925511
- PMCID: PMC9556385
- DOI: 10.1007/s11886-022-01746-w
Diagnostic and Management Strategies in Patients with Late Recurrent Angina after Coronary Artery Bypass Grafting
Abstract
Purpose of review: This review will outline the current evidence on the anatomical, functional, and physiological tools that may be applied in the evaluation of patients with late recurrent angina after coronary artery bypass grafting (CABG). Furthermore, we discuss management strategies and propose an algorithm to guide decision-making for this complex patient population.
Recent findings: Patients with prior CABG often present with late recurrent angina as a result of bypass graft failure and progression of native coronary artery disease (CAD). These patients are generally older, have a higher prevalence of comorbidities, and more complex atherosclerotic lesion morphology compared to CABG-naïve patients. In addition, guideline recommendations are based on studies in which post-CABG patients have been largely excluded. Several invasive and non-invasive diagnostic tools are currently available to assess graft patency, the hemodynamic significance of native CAD progression, left ventricular function, and myocardial viability. Such tools, in particular the latest generation coronary computed tomography angiography, are part of a systematic diagnostic work-up to guide optimal repeat revascularization strategy in patients presenting with late recurrent angina after CABG.
Keywords: Diagnostic algorithm; Late recurrent angina; Prior coronary artery bypass grafting; Repeat revascularization.
© 2022. The Author(s).
Conflict of interest statement
None declared.
Figures





Similar articles
-
Multidetector computed tomography in previous coronary artery bypass grafting: implications for secondary revascularisation.EuroIntervention. 2009 May;5 Suppl D:D37-44. EuroIntervention. 2009. PMID: 19736069 Review.
-
Clinical and Angiographic Predictors of Patient-Reported Angina 1 Year After Coronary Artery Bypass Graft Surgery.Circ Cardiovasc Qual Outcomes. 2019 Apr;12(4):e005119. doi: 10.1161/CIRCOUTCOMES.118.005119. Circ Cardiovasc Qual Outcomes. 2019. PMID: 31001997
-
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.Circ Cardiovasc Qual Outcomes. 2012 May;5(3):267-75. doi: 10.1161/CIRCOUTCOMES.111.964585. Epub 2012 Apr 10. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22496114 Clinical Trial.
-
Impact of treatment strategies on outcomes in patients with stable coronary artery disease and type 2 diabetes mellitus according to presenting angina severity: A pooled analysis of three federally-funded randomized trials.Atherosclerosis. 2018 Oct;277:186-194. doi: 10.1016/j.atherosclerosis.2018.04.005. Epub 2018 Jun 1. Atherosclerosis. 2018. PMID: 29861270
-
Isolated disease of the proximal left anterior descending artery comparing the effectiveness of percutaneous coronary interventions and coronary artery bypass surgery.JACC Cardiovasc Interv. 2008 Oct;1(5):483-91. doi: 10.1016/j.jcin.2008.07.001. JACC Cardiovasc Interv. 2008. PMID: 19463349 Review.
Cited by
-
Correlation and Agreement of Quantitative Flow Ratio With Fractional Flow Reserve in Saphenous Vein Grafts.J Am Heart Assoc. 2024 Nov 5;13(21):e034901. doi: 10.1161/JAHA.124.034901. Epub 2024 Oct 18. J Am Heart Assoc. 2024. PMID: 39424401 Free PMC article.
-
The Role of Preservation Solutions upon Saphenous Vein Endothelial Integrity and Function: Systematic Review and UK Practice Survey.Cells. 2023 Mar 6;12(5):815. doi: 10.3390/cells12050815. Cells. 2023. PMID: 36899951 Free PMC article.
-
Comparison of Fractional Flow Reserve and Myocardial Perfusion Imaging in Saphenous Vein Grafts.Catheter Cardiovasc Interv. 2025 May;105(6):1365-1374. doi: 10.1002/ccd.31467. Epub 2025 Feb 24. Catheter Cardiovasc Interv. 2025. PMID: 39991799 Free PMC article.
-
Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation.J Transl Med. 2024 Feb 16;22(1):166. doi: 10.1186/s12967-024-04875-8. J Transl Med. 2024. PMID: 38365767 Free PMC article.
References
-
- • Neumann F-J, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2018;40(2):87-165. Most recent myocardial revascularization guidelines. - PubMed
-
- • Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021. Most recent myocardial revascularization guidelines. - PubMed
-
- Fearon WF, Zimmermann FM, De Bruyne B, et al. Fractional flow reserve-guided PCI as compared with coronary bypass surgery. N Engl J Med. 2021. - PubMed
-
- Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients. J Am Coll Cardiol. 2002;40(11):1951–1954. doi: 10.1016/S0735-1097(02)02560-3. - DOI - PubMed
-
- Sabik JF, 3rd, Blackstone EH, Gillinov AM, et al. Occurrence and risk factors for reintervention after coronary artery bypass grafting. Circulation. 2006;114(1 Suppl):I454–I460. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous